The Healthcare Costs of Sarcopenia in the United States

By Ian Janssen, D. Shepard, P. Katzmarzyk, Ronenn Roubenoff. Journal of The American Geriatrics Society, 2004

1,481 citations recorded by the source corpus.

Subfields: Geriatrics and Gerontology, Physiology, Speech and Hearing

View Paper: https://www.semanticscholar.org/paper/85c23d9d55c707aa9ed769623dc329507c6517dd

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. Tamara B. Harris
2. R. Baumgartner
3. Anne B. Newman
4. W. Westcott

Citations in the corpus

• Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. (2013, background): “The age-related muscle mass loss is also associated with an increased risk of incident disability, all-cause mortality and higher health-care costs in the older people [1, 7].”
• Clinical definition of sarcopenia. (2014, background): “The impact of sarcopenia on older people is far reaching; its substantial tools are measured in terms of morbidity, disability, high costs of health care and mortality (16-20).”
• Resistance Training is Medicine: Effects of Strength Training on Health (2012, background): “Given the serious problem of sarcopenia in an increasingly sedentary and aging population (71), and the accumulating evidence that resistance exercise promotes muscle gains in men and women of all ages (144), it is understandable that leading researchers have advocated a public health mandate for se”
• Sarcopenia: Its assessment, etiology, pathogenesis, consequences and future perspectives (2008, background): “The annual healthcare cost attributable to sarcopenia is estimated at $18 billion in the United States alone (16).”
• Nutritional Recommendations for the Management of Sarcopenia (2010, neutral): “Sarcopenia is not necessarily associated with weight loss and therefore is distinct from cachexia.(19) Obese sarcopenic persons appear to have even worse outcomes.”
• Sarcopenia: European consensus on definition and diagnosis (2010, background): “The impact of sarcopenia on older people is far reaching; its substantial tolls are measured in terms of morbidity [73], disability [67], high costs of health care [74] and mortality [75].”
• Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. (2011, background): “(17) estimated that sarcopenia results in an excess cost to the health care system of the United States of $18.”